chr13-48373406-A-T
Variant summary
Our verdict is Benign. Variant got -18 ACMG points: 2P and 20B. PM1BP4_StrongBP6_Very_StrongBS1BS2
The NM_000321.3(RB1):c.1129A>T(p.Thr377Ser) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000147 in 1,570,090 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/23 in silico tools predict a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_000321.3 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RB1 | NM_000321.3 | c.1129A>T | p.Thr377Ser | missense_variant, splice_region_variant | 12/27 | ENST00000267163.6 | NP_000312.2 | |
LOC112268118 | XR_002957522.2 | n.121+754T>A | intron_variant, non_coding_transcript_variant | |||||
RB1 | NM_001407165.1 | c.1129A>T | p.Thr377Ser | missense_variant, splice_region_variant | 12/27 | NP_001394094.1 | ||
RB1 | NM_001407166.1 | c.1129A>T | p.Thr377Ser | missense_variant, splice_region_variant | 12/17 | NP_001394095.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RB1 | ENST00000267163.6 | c.1129A>T | p.Thr377Ser | missense_variant, splice_region_variant | 12/27 | 1 | NM_000321.3 | ENSP00000267163 | P1 | |
RB1 | ENST00000650461.1 | c.1129A>T | p.Thr377Ser | missense_variant, splice_region_variant | 12/27 | ENSP00000497193 |
Frequencies
GnomAD3 genomes AF: 0.000743 AC: 113AN: 152016Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000224 AC: 56AN: 250420Hom.: 0 AF XY: 0.000192 AC XY: 26AN XY: 135372
GnomAD4 exome AF: 0.0000832 AC: 118AN: 1417958Hom.: 1 Cov.: 27 AF XY: 0.0000763 AC XY: 54AN XY: 707860
GnomAD4 genome AF: 0.000743 AC: 113AN: 152132Hom.: 0 Cov.: 32 AF XY: 0.000538 AC XY: 40AN XY: 74382
ClinVar
Submissions by phenotype
Retinoblastoma Benign:2
Likely benign, criteria provided, single submitter | clinical testing | Mendelics | May 28, 2019 | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
Hereditary cancer-predisposing syndrome Benign:2
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 07, 2018 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Benign, criteria provided, single submitter | curation | Sema4, Sema4 | Jan 04, 2021 | - - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | May 18, 2021 | In silico analysis, which includes protein predictors and evolutionary conservation, supports that this variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 28780672, 26332594, 14769601) - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at